Pharmacists in Palm Springs, California


156 Pharmacists found in Palm Springs
male pharmacist

Tommy J Jung


Pharmacist
4733 E Palm Canyon Dr, Palm Springs, CA 92264
760-324-8269    

female pharmacist

Trinity Thienanh Khoa Do, PHARMD, MBA


Pharmacist
5601 E Ramon Rd, Palm Springs, CA 92264
760-322-1488     760-322-8059

female pharmacist

Dr. Triny Fueng Thai, PHARMD


Pharmacist
1150 N Indian Canyon Dr, Palm Springs, CA 92262
760-323-6511    



female pharmacist

Vedanshi Bhojak


Pharmacist
255 N El Cielo Rd Ste C326, Palm Springs, CA 92262
760-969-6560    

male pharmacist

Viet The Nguyen, PHARMD


Pharmacist
1150 N Indian Canyon Dr, Palm Springs, CA 92262
760-323-6511    

female pharmacist

Vivian Nguyen Luu, PHARMACY RESIDENT



1180 N Indian Canyon Dr Ste E140, Palm Springs, CA 92262
760-323-1001    

female pharmacist

Vyhan Nguyen


Pharmacist
1700 E Vista Chino, Palm Springs, CA 92262
760-864-1516    

female pharmacist

Dr. Wendy Jimenez, PHARMD


Pharmacist
255 N El Cielo Rd Ste C326, Palm Springs, CA 92262
656-076-0969    

male pharmacist

William Kresel Jr., BS PHARMACY


Pharmacist
4733 E Palm Canyon Dr, Palm Springs, CA 92264
760-324-8269     760-202-3432

female pharmacist

Xin Pan


Pharmacist
275 N El Cielo Rd, Palm Springs, CA 92262
760-320-8814    

female pharmacist

Yasmine Christine Khader, PHARMD


Pharmacist
1180 N Indian Canyon Dr Ste E140, Palm Springs, CA 92262
760-323-1001    

male pharmacist

Dr. Zachary Charles Hackworth, PHARMD


Pharmacist
255 N El Cielo Rd Ste C-326, Palm Springs, CA 92262
760-969-6560     760-328-2230


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.